Insider · CIK 0001277631

Baskett Forest

CIK 0001277631 Name as filed on the most recent filing

Filed as Baskett Forest (198)

362 transaction lines · from 198 filings · filed 2005-08-01 to 2026-03-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

269 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-03-02 P, Open-market purchase Tesaro, Inc.TSRO 57,794, acquired Open Form 4 filing 0001209191-18-017557
2018-02-26 S, Open-market sale Arca biopharma, Inc.ABIO 731,273, disposed Open Form 4 filing 0001209191-18-013931
2018-02-16 P, Open-market purchase Ra Pharmaceuticals, Inc.RARX 12,000,000, acquired Open Form 4 filing 0001209191-18-011903
2017-12-18 P, Open-market purchase Proteostasis Therapeutics, Inc.PTI 10,000,000, acquired Open Form 4 filing 0001209191-17-066249
2017-11-27 S, Open-market sale Appian CorpAPPN 11,101,894, disposed Open Form 4 filing 0001209191-17-062618
2017-11-20 S, Open-market sale Appian CorpAPPN 54,971,857, disposed Open Form 4 filing 0001209191-17-062088
2017-10-10 P, Open-market purchase Rhythm Pharmaceuticals, Inc.RYTM 9,350,000, acquired Open Form 4 filing 0001209191-17-056461
2017-08-30 S, Open-market sale Ardelyx, Inc.ARDX 2,401, disposed Open Form 4 filing 0001209191-17-050902
2017-07-03 P, Open-market purchase Mersana Therapeutics, Inc.MRSN 15,000,000, acquired Open Form 4 filing 0001209191-17-044146
2017-03-28 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 3,000,000, acquired Open Form 4 filing 0001209191-17-023487
2017-03-27 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 9,009,000, acquired Open Form 4 filing 0001209191-17-023144
2017-02-13 S, Open-market sale Zosano Pharma CorpZSAN 2,211,432, disposed Open Form 4 filing 0001209191-17-010557
2016-12-19 P, Open-market purchase Achaogen IncAKAO 6,750,000, acquired Open Form 4 filing 0001209191-16-155936
2016-12-05 S, Open-market sale Tableau Software IncDATA 494,659, disposed Open Form 4 filing 0001209191-16-153680
2016-11-29 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 4,999,999, acquired Open Form 4 filing 0001209191-16-152351
2016-10-31 S, Open-market sale Ra Pharmaceuticals, Inc.RARX 5,655, disposed Open Form 4 filing 0001209191-16-147484
2016-10-31 P, Open-market purchase Ra Pharmaceuticals, Inc.RARX 4,400,006, acquired Open Form 4 filing 0001209191-16-147484
2016-09-16 S, Open-market sale Zosano Pharma CorpZSAN 5,603, disposed Open Form 4 filing 0001209191-16-142163
2016-09-14 P, Open-market purchase Proteostasis Therapeutics, Inc.PTI 5,999,994, acquired Open Form 4 filing 0001209191-16-141608
2016-09-13 S, Open-market sale Zosano Pharma CorpZSAN 7,400, disposed Open Form 4 filing 0001209191-16-141605
2016-08-29 S, Open-market sale Zosano Pharma CorpZSAN 50,440, disposed Open Form 4 filing 0001209191-16-139316
2016-08-24 S, Open-market sale Zosano Pharma CorpZSAN 1,452, disposed Open Form 4 filing 0001209191-16-138820
2016-07-29 P, Open-market purchase Interleukin Genetics IncILIU 2,000,000, acquired Open Form 4 filing 0001209191-16-134925
2016-07-21 S, Open-market sale Zosano Pharma CorpZSAN 11,957, disposed Open Form 4 filing 0001209191-16-133608
2016-07-20 S, Open-market sale Zosano Pharma CorpZSAN 17,550, disposed Open Form 4 filing 0001209191-16-133608
2016-07-19 S, Open-market sale Zosano Pharma CorpZSAN 625, disposed Open Form 4 filing 0001209191-16-133608
2016-07-18 P, Open-market purchase Ardelyx, Inc.ARDX 3 lines 20,000,002, acquired Open Form 4 filing 0001209191-16-133482
2016-07-13 S, Open-market sale Zosano Pharma CorpZSAN 16,060, disposed Open Form 4 filing 0001209191-16-132900
2016-06-07 S, Open-market sale Tableau Software IncDATA 4 lines 4,043,436, disposed Open Form 4 filing 0001209191-16-126602
2016-03-18 P, Open-market purchase Tesaro, Inc.TSRO 2 lines 49,999,993, acquired Open Form 4 filing 0001209191-16-109540
2016-02-17 P, Open-market purchase Proteostasis Therapeutics, Inc.PTI 7,202,592, acquired Open Form 4 filing 0001209191-16-099506
2016-01-13 P, Open-market purchase Ardelyx, Inc.ARDX 3 lines 15,000,000, acquired Open Form 4 filing 0001209191-16-091426
2016-01-12 P, Open-market purchase Epizyme, Inc.EPZM 9,999,999, acquired Open Form 4 filing 0001209191-16-091065
2015-11-24 S, Open-market sale Tableau Software IncDATA 2,505,914, disposed Open Form 4 filing 0001209191-15-081985
2015-10-06 P, Open-market purchase Mirna Therapeutics, Inc.MIRN 5,999,994, acquired Open Form 4 filing 0001209191-15-074303
2015-06-17 S, Open-market sale Supernus Pharmaceuticals IncSUPN 2 lines 1,833,603, disposed Open Form 4 filing 0001181431-15-008494
2015-06-16 S, Open-market sale Supernus Pharmaceuticals IncSUPN 2 lines 1,878,080, disposed Open Form 4 filing 0001181431-15-008372
2015-06-05 P, Open-market purchase Ardelyx, Inc.ARDX 3 lines 49,999,998, acquired Open Form 4 filing 0001181431-15-008055

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 116
  • Open-market sale 153
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BASKETT FOREST, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001277631

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.